HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Motoshige Yasuike Selected Research

Infections

1/2018Antibody profiling using a recombinant protein-based multiplex ELISA array accelerates recombinant vaccine development: Case study on red sea bream iridovirus as a reverse vaccinology model.
1/2016Full-Genome Sequencing and Confirmation of the Causative Agent of Erythrocytic Inclusion Body Syndrome in Coho Salmon Identifies a New Type of Piscine Orthoreovirus.
3/2014Comparative transcriptomics of Atlantic Salmo salar, chum Oncorhynchus keta and pink salmon O. gorbuscha during infections with salmon lice Lepeophtheirus salmonis.
3/2011Gene expression profile of HIRRV G and N protein gene vaccinated Japanese flounder, Paralichthys olivaceus during HIRRV infection.
1/2011Identification and characterization of Japanese flounder, Paralichthys olivaceus interferon-stimulated gene 15 (Jf-ISG15).
11/2010Differential gene expression profiles in Japanese flounder (Paralichthys olivaceus) with different susceptibilities to edwardsiellosis.
12/2007Molecular characterization and gene expression of a CXC chemokine gene from Japanese flounder Paralichthys olivaceus.
10/2007Transcriptional profile of red seabream iridovirus in a fish model as revealed by viral DNA microarrays.
12/2005Transcription program of red sea bream iridovirus as revealed by DNA microarrays.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Motoshige Yasuike Research Topics

Disease

9Infections
01/2018 - 12/2005
3Virus Diseases (Viral Diseases)
02/2016 - 09/2007
2Inflammation (Inflammations)
03/2014 - 01/2005
1Nocardia Infections
01/2017
1Anemia
01/2016
1Acute-Phase Reaction
03/2014
1Coinfection
03/2014
1Bacterial Infections (Bacterial Infection)
07/2008
1Neutropenia
06/2006
1Neoplasms (Cancer)
06/2006

Drug/Important Bio-Agent (IBA)

4Antiviral Agents (Antivirals)IBA
03/2014 - 10/2007
3Poly I-CIBA
02/2016 - 09/2007
3CytokinesIBA
03/2014 - 06/2006
1Synthetic Vaccines (Recombinant Vaccines)IBA
01/2018
1AntibodiesIBA
01/2018
1Virulence Factors (Pathogenicity Factors)IBA
01/2017
1LipopolysaccharidesIBA
02/2016
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
02/2016
1RNA (Ribonucleic Acid)IBA
01/2016
1Hydrocortisone (Cortisol)FDA LinkGeneric
03/2014
1Complement System Proteins (Complement)IBA
03/2014
1Pattern Recognition ReceptorsIBA
03/2014
1IronIBA
03/2014
1Proteins (Proteins, Gene)FDA Link
03/2011
1A-Form DNA (A-DNA)IBA
03/2011
1Gallus gallus interferon regulatory factor-10IBA
01/2011
1Complementary DNA (cDNA)IBA
11/2010
1Peptides (Polypeptides)IBA
12/2007
1ChemokinesIBA
12/2007
1Dihydrotachysterol (AT 10)IBA
10/2007
1Interferon Type IIBA
09/2007
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2006
1Glycoproteins (Glycoprotein)IBA
06/2006
1Viral DNAIBA
12/2005
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2005
1Collagenases (Collagenase)FDA Link
01/2005

Therapy/Procedure

1Therapeutics
06/2006